Bilsborough Lab

Personal Statement

I was recruited to Cedars-Sinai to direct the Inflammatory Bowel Diseases Drug Discovery and Development (IBD3) unit for the Inflammatory Bowel and Immunobiology Research Institute. IBD3 is a unique concept by design, in which an industry-caliber target discovery and development unit is integrated with an academic research program to accelerate the pace at which scientific findings are brought to bear on patient care."

Janine Bilsborough, PhD

The Bilsborough Laboratory's Inflammatory Bowel Diseases Drug Discovery and Development unit is composed of research scientists and clinicians with experience in both the biopharmaceutical industry and clinical research.

Meet Our Team

Learn more about the scientists, faculty members, investigators and other healthcare professionals of the Bilsborough Laboratory, whose dedicated efforts lead to groundbreaking discoveries.

Bilsborough J.

Nat Immunol. 2015 Feb;16(2):137-139

Bilsborough J, Mudri S, Chadwick E, Harder B, Dillon SR.

J Immunol. 2010 Nov 15;185(10):6023-6030.

Contact the Bilsborough Lab

8693 Wilshire Blvd., 
Second floor
Beverly Hills, CA 90211